Results 51 to 60 of about 10,263,709 (301)

Emapalumab for Immune Effector Cell‐Associated Hemophagocytic Lymphohistiocytosis‐Like Syndrome Following CD19‐Directed CAR‐T in Two Patients With B‐ALL: Clinical and Biomarker Correlates

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Immune effector cell‐associated hemophagocytic lymphohistiocytosis‐like syndrome (IEC‐HS) is a life‐threatening hyperinflammatory toxicity distinct from cytokine release syndrome (CRS) and neurotoxicity following chimeric antigen receptor T‐cell (CAR‐T) therapy. In a single‐institution retrospective cohort of pediatric and young adult patients
Thomas J. Galletta   +6 more
wiley   +1 more source

Enhanced CNN for image denoising

open access: yesCAAI Transactions on Intelligence Technology, 2019
Owing to the flexible architectures of deep convolutional neural networks (CNNs) are successfully used for image denoising. However, they suffer from the following drawbacks: (i) deep network architecture is very difficult to train.
Chunwei Tian   +5 more
doaj   +1 more source

The Role of Hematopoietic Cell Transplantation in Ataxia‐Telangiectasia

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Ataxia‐telangiectasia (A‐T) is a DNA repair disorder characterized by neurodegeneration, immunodeficiency, and cancer predisposition. Hematopoietic cell transplantation (HCT) is an established therapy in related disorders such as Fanconi anemia (FA) and Nijmegen breakage syndrome (NBS), but its role in A‐T is unclear.
Laila Alkhouli   +3 more
wiley   +1 more source

Increased Risk of Sarcomas in Children With Congenital Anomalies: Findings From the Genetic Overlap Between Anomalies and Cancer in Kids (GOBACK) Registry Linkage Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Pediatric sarcomas are a heterogeneous group of tumors that contribute disproportionately to cancer mortality in children. Although congenital anomalies are among the strongest known risk factors for childhood cancer, the risk of specific sarcoma subtypes among affected individuals has not yet been thoroughly evaluated. Procedure We
Russ Wolters   +17 more
wiley   +1 more source

Authors publication strategies in scholarly publishing [PDF]

open access: yes, 2010
In this exploratory study, we analyze publishing patterns of authors from different disciplines, as part of a broader analysis of the transformation of the scholarly publishing industry.
P. Galimberti   +5 more
core  

Supporting Survivor‐Centered Care Through Digital Health Integration

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Survivors of childhood cancer face barriers to receiving guideline‐based, long‐term follow‐up care. Two digital tools, Passport for Care (PFC) and Cancer SurvivorLink (SurvivorLink), address complementary gaps by enabling tailored survivorship care plan (SCP) generation, updating, storage, and sharing.
Jordan G. Marchak   +15 more
wiley   +1 more source

Going Beyond Counting First Authors in Author Co-citation Analysis [PDF]

open access: yes, 2005
The present study examines one of the fundamental aspects of author co-citation analysis (ACA) - the way co-citation counts are defined. Co-citation counting provides the data on which all subsequent statistical analyses and mappings are based, and we ...
Zhao, Dangzhi
core  

Fair Use for Nonfiction Authors [PDF]

open access: yes, 2017
The Authors Alliance guide to Fair Use for Nonfiction Authors is designed to empower authors to exercise their right to use source materials to further their research and writing goals by helping them to make confident fair use decisions.
Walker, Robert Kirk   +1 more
core   +1 more source

Efficacy and Safety Analysis of Roxarestat in Regulating Renal Anemia in Patients on Maintenance Hemodialysis

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Objective To compare the efficacy and safety of roxarestat versus recombinant human erythropoietin (rhEPO) in the management of renal anemia in patients undergoing maintenance hemodialysis. Methods This was a prospective, open‐label, randomized controlled trial.
Lingling Chen, Junjie Zhu, Qiaonan Ge
wiley   +1 more source

Open Data for Open Innovation: An Analysis of Literature Characteristics

open access: yesFuture Internet, 2019
In this paper, we review some characteristics of the literature that studies the uses and applications of open data for open innovation. Three research questions are proposed about both topics: (1) What journals, conferences and authors have published ...
Diego Corrales-Garay   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy